Funding
Researcher : José Luis Lanciego Pérez
6 funding - 1,124,191€
2024
-
Safety, Tolerability, Toxicity and Biodistribution Study Aft
euro 153,578.00
2021
-
ASAP/MJFF: Activity and connectivity drive neuronal vulnerability and disease progression in Parkinson¿s disease
euro 453,240.00
-
Uso de vectores virales adeno-asociados para el diseño y validación de modelos fisiopatológicos de enfermedad de Parkinson en primates no humanos (GENEPARK)
euro 145,200.00
2020
-
Comorbidity mechanisms of anxiety and Parkinson's
euro 130,625.00